Mengxia Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mengxia Gao has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Tatia Mei Chun Lee
State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China
4 shared publications - Antonio Verdejo-García
School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia
2 shared publications Changwei Wu
Brain and Consciousness Research Center, Shuang-Ho Hospital, New Taipei, Taiwan
2 shared publications- Chemin Lin
Department of Psychiatry Keelung Chang Gung Memorial Hospital Keelung Taiwan
2 shared publications - Chih-Mao Huang
Department of Psychology, The University of Hong Kong, Hong Kong
2 shared publications Ho-Ling Liu
Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in Scientific Reports
Baseline network connectivity is longitudinally associated with internalizing symptoms through conduct problems in adolescents
- 28 October 2026
- Published by Springer Nature in Scientific Reports
Open AccessBaseline network connectivity is longitudinally associated with internalizing symptoms through conduct problems in adolescents
- Open Access
- 2 May 2026
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- p. 1-37
Harnessing food cue evoked neuroimaging towards treatment optimisation for obesity and binge eating disorder
Obesity and binge eating disorder (BED) are global health concerns that share overlapping neural mechanisms. These include alterations in the brain’s reward and control systems leading to heightened sensitivity to food cues and impaired self-regulation, which underpin overeating. Identifying neuroimaging-based biomarkers that index these mechanisms could advance individualised treatments. This scoping review examined evidence on fMRI food cue reactivity as a potential approach for developing predictive and response biomarkers relevant to the treatment of obesity and BED. A systematic search of MEDLINE, Scopus, PsycINFO, and Embase (to July 2025) identified 57 eligible studies incorporating fMRI cue reactivity measures in the context of pharmacological, surgical, psychological, and lifestyle interventions. Of these, 7 reported predictive outcomes only (6 for adults with obesity and 1 for children and adolescents with obesity), 41 reported response outcomes only (36 for adults with obesity, 3 for children and adolescents with obesity and 2 for adults with binge eating), and 9 reported both predictive and response outcomes (8 for adults with obesity and 1 for adults with binge eating). Across paradigms and intervention modalities, there was consistent involvement of reward (striatum, insula, orbitofrontal and ventromedial prefrontal cortex) and cognitive control regions (dorsolateral and dorsomedial prefrontal cortex) as response outcomes from successful treatment. Reductions in reward-system reactivity following interventions were consistently associated with improved clinical outcomes, supporting the potential of fMRI food cue reactivity as a candidate biomarker of treatment response. However, this finding is highly skewed towards obesity, given the limited number of studies that report results for BED (3 studies). Furthermore, consistent evidence for reliable predictive biomarkers was also limited, likely due to methodological variability and small sample sizes. Overall, this review supports the potential of response outcomes from fMRI food cue reactivity as an indicator of treatment efficacy in obesity and highlights the limited evidence in BED. We also emphasise the need for further standardisation of paradigms and biomarker validation efforts.
- 2 May 2026
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- p. 1-37
Open AccessHarnessing food cue evoked neuroimaging towards treatment optimisation for obesity and binge eating disorder
Obesity and binge eating disorder (BED) are global health concerns that share overlapping neural mechanisms. These include alterations in the brain’s reward and control systems leading to heightened sensitivity to food cues and impaired self-regulation, which underpin overeating. Identifying neuroimaging-based biomarkers that index these mechanisms could advance individualised treatments. This scoping review examined evidence on fMRI food cue reactivity as a potential approach for developing predictive and response biomarkers relevant to the treatment of obesity and BED. A systematic search of MEDLINE, Scopus, PsycINFO, and Embase (to July 2025) identified 57 eligible studies incorporating fMRI cue reactivity measures in the context of pharmacological, surgical, psychological, and lifestyle interventions. Of these, 7 reported predictive outcomes only (6 for adults with obesity and 1 for children and adolescents with obesity), 41 reported response outcomes only (36 for adults with obesity, 3 for children and adolescents with obesity and 2 for adults with binge eating), and 9 reported both predictive and response outcomes (8 for adults with obesity and 1 for adults with binge eating). Across paradigms and intervention modalities, there was consistent involvement of reward (striatum, insula, orbitofrontal and ventromedial prefrontal cortex) and cognitive control regions (dorsolateral and dorsomedial prefrontal cortex) as response outcomes from successful treatment. Reductions in reward-system reactivity following interventions were consistently associated with improved clinical outcomes, supporting the potential of fMRI food cue reactivity as a candidate biomarker of treatment response. However, this finding is highly skewed towards obesity, given the limited number of studies that report results for BED (3 studies). Furthermore, consistent evidence for reliable predictive biomarkers was also limited, likely due to methodological variability and small sample sizes. Overall, this review supports the potential of response outcomes from fMRI food cue reactivity as an indicator of treatment efficacy in obesity and highlights the limited evidence in BED. We also emphasise the need for further standardisation of paradigms and biomarker validation efforts.
- Open Access
- 2 July 2025
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 46, 101515
Trialing addiction neurocircuitry targets and directionality of brain stimulation effects: A deep TMS/fMRI trial in people with alcohol use disorder
- 2 July 2025
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 46, 101515
Open AccessTrialing addiction neurocircuitry targets and directionality of brain stimulation effects: A deep TMS/fMRI trial in people with alcohol use disorder
- Open Access
- 11 May 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 175, 374-380
A machine-learning approach to model risk and protective factors of vulnerability to depression
- 11 May 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 175, 374-380
Open AccessA machine-learning approach to model risk and protective factors of vulnerability to depression
- Open Access
- 17 February 2023
- Published by Springer Nature in Nature Mental Health
- Vol. 1 (2) , 100-113
Multimodal brain connectome-based prediction of suicide risk in people with late-life depression
Suicidal ideation, plans and behavior are particularly serious health issues among the older population, resulting in a higher likelihood of deaths than in any other age group. The increasing prevalence of depression in late life reflects the urgent need for efficient screening of suicide risk in people with late-life depression. Employing a cross-sectional design, we performed connectome-based predictive modelling using whole-brain resting-state functional connectivity and white matter structural connectivity data to predict suicide risk in late-life depression patients (N = 37 non-suicidal patients, N = 24 patients with suicidal ideation/plan, N = 30 patients who attempted suicide). Suicide risk was measured using three standardized questionnaires. Brain connectivity profiles were used to classify three groups in our dataset and two independent datasets using machine learning. We found that brain patterns could predict suicide risk in the late-life depression population, with the explained variance up to 30.34%. The functional and structural connectivity profiles improved the classification-prediction accuracy compared with using questionnaire scores alone and could be applied to identify depressed patients who had higher suicide risk in two independent datasets. Our findings suggest that multimodal brain connectivity could capture individual differences in suicide risk among late-life depression patients. Our predictive models might be further tested to help clinicians identify patients who need detailed assessments and interventions. The trial registration number for this study is ChiCTR2200066356.
- 17 February 2023
- Published by Springer Nature in Nature Mental Health
- Vol. 1 (2) , 100-113
Open AccessMultimodal brain connectome-based prediction of suicide risk in people with late-life depression
Suicidal ideation, plans and behavior are particularly serious health issues among the older population, resulting in a higher likelihood of deaths than in any other age group. The increasing prevalence of depression in late life reflects the urgent need for efficient screening of suicide risk in people with late-life depression. Employing a cross-sectional design, we performed connectome-based predictive modelling using whole-brain resting-state functional connectivity and white matter structural connectivity data to predict suicide risk in late-life depression patients (N = 37 non-suicidal patients, N = 24 patients with suicidal ideation/plan, N = 30 patients who attempted suicide). Suicide risk was measured using three standardized questionnaires. Brain connectivity profiles were used to classify three groups in our dataset and two independent datasets using machine learning. We found that brain patterns could predict suicide risk in the late-life depression population, with the explained variance up to 30.34%. The functional and structural connectivity profiles improved the classification-prediction accuracy compared with using questionnaire scores alone and could be applied to identify depressed patients who had higher suicide risk in two independent datasets. Our findings suggest that multimodal brain connectivity could capture individual differences in suicide risk among late-life depression patients. Our predictive models might be further tested to help clinicians identify patients who need detailed assessments and interventions. The trial registration number for this study is ChiCTR2200066356.
- Open Access
- 1 September 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (9) , 905-915
Multimodal Neural Evidence on the Corticostriatal Underpinning of Suicidality in Late-Life Depression
- 1 September 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (9) , 905-915
Open AccessMultimodal Neural Evidence on the Corticostriatal Underpinning of Suicidality in Late-Life Depression